|Articles|February 19, 2014
LCGC TV: Koen Sandra on Analyzing Protein Biopharmaceuticals Using LC–MS
By 2020, more than 50% of approved drugs are expected to be protein biopharmaceuticals. Koen Sandra from the Research Institute for Chromatography in Belgium discusses the challenges of characterizing protein biopharmaceuticals and why LC–MS is now indispensable for characterizing this class of drugs.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on LCGC International
1
Py-GC/MS Detects Microplastics in Pediatric Asthma Patients
2
Industry Roundup: Shimadzu Unveils New High-End UHPLC System Aimed at Reducing Laboratory Downtime
3
Industry Roundup: Thermo Fisher Unveils Orbitrap Isora IRMS System
4
Industry Roundup: Gerstel Showcased New Twister Phases and Automated Liner Exchange Technology at EPRW 2026 in Rotterdam
5